Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (3): 230-234.DOI: 10.3969/j.issn.1673-8640.2025.03.005
Previous Articles Next Articles
ZHENG Ying, LU Zhe, XUE Jing
Received:2024-05-06
Revised:2024-11-03
Online:2025-03-30
Published:2025-04-10
CLC Number:
ZHENG Ying, LU Zhe, XUE Jing. Relationship between serum 25(OH)D3 level and lymphocyte subsets in children with systemic lupus erythematosus[J]. Laboratory Medicine, 2025, 40(3): 230-234.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.03.005
| 组别 | 例数 | 肌酐/ (μmol·L-1) | C3/ (g·L-1) | C4/ (g·L-1) | 抗dsDNA抗体/ (IU·mL-1) | 抗Sm抗体/ (AU·mL-1) | 抗RNP70抗体/ (AU·mL-1) |
|---|---|---|---|---|---|---|---|
| SLE组 | 52 | 57.66±11.34 | 0.74±0.23 | 0.16±0.08 | 84.37±11.38 | 76.24±15.34 | 23.90±11.12 |
| 正常对照组 | 50 | 40.89±7.28 | 1.15±0.29 | 0.30±0.12 | 15.29±2.17 | 5.34±0.99 | 2.46±0.42 |
| t值 | 15.01 | 14.56 | 20.15 | 52.41 | 66.41 | 60.00 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| 组别 | 例数 | 肌酐/ (μmol·L-1) | C3/ (g·L-1) | C4/ (g·L-1) | 抗dsDNA抗体/ (IU·mL-1) | 抗Sm抗体/ (AU·mL-1) | 抗RNP70抗体/ (AU·mL-1) |
|---|---|---|---|---|---|---|---|
| SLE组 | 52 | 57.66±11.34 | 0.74±0.23 | 0.16±0.08 | 84.37±11.38 | 76.24±15.34 | 23.90±11.12 |
| 正常对照组 | 50 | 40.89±7.28 | 1.15±0.29 | 0.30±0.12 | 15.29±2.17 | 5.34±0.99 | 2.46±0.42 |
| t值 | 15.01 | 14.56 | 20.15 | 52.41 | 66.41 | 60.00 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| 组别 | 例数 | 25(OH)D3/(nmol·L-1) | CD3+T细胞/ % | CD4+T细胞/ % | CD8+T细胞/ % | CD4+/CD8+ 比值 | NK细胞/ % | 总B细胞/ % |
|---|---|---|---|---|---|---|---|---|
| SLE组 | 52 | 59.72±14.67 | 75.96±15.28 | 30.04±9.14 | 39.91±16.85 | 0.93±0.22 | 9.34±3.14 | 13.01±2.85 |
| 正常对照组 | 50 | 66.90±20.38 | 69.71±14.44 | 34.40±5.11 | 30.24±11.48 | 1.18±0.28 | 12.97±2.78 | 14.67±3.02 |
| t值 | 2.035 | 2.124 | 2.156 | 3.399 | 5.001 | 6.188 | 2.853 | |
| P值 | 0.044 | 0.036 | 0.028 | 0.001 | <0.001 | <0.001 | 0.005 |
| 组别 | 例数 | 25(OH)D3/(nmol·L-1) | CD3+T细胞/ % | CD4+T细胞/ % | CD8+T细胞/ % | CD4+/CD8+ 比值 | NK细胞/ % | 总B细胞/ % |
|---|---|---|---|---|---|---|---|---|
| SLE组 | 52 | 59.72±14.67 | 75.96±15.28 | 30.04±9.14 | 39.91±16.85 | 0.93±0.22 | 9.34±3.14 | 13.01±2.85 |
| 正常对照组 | 50 | 66.90±20.38 | 69.71±14.44 | 34.40±5.11 | 30.24±11.48 | 1.18±0.28 | 12.97±2.78 | 14.67±3.02 |
| t值 | 2.035 | 2.124 | 2.156 | 3.399 | 5.001 | 6.188 | 2.853 | |
| P值 | 0.044 | 0.036 | 0.028 | 0.001 | <0.001 | <0.001 | 0.005 |
| 组别 | 例数 | CD3+T细胞/% | CD4+T细胞/% | CD8+T细胞/% | CD4+/CD8+比值 | NK细胞/% | 总B细胞/% |
|---|---|---|---|---|---|---|---|
| 维生素D正常组 | 32 | 70.13±11.14 | 36.13±7.23 | 37.91±14.18 | 0.98±0.27 | 9.96±4.05 | 14.21±2.99 |
| 维生素D不足组 | 20 | 88.44±18.46 | 24.12±4.28 | 58.46±17.36 | 0.57±0.18 | 7.32±2.02 | 10.02±2.11 |
| t值 | 2.530 | 7.606 | 7.769 | 5.154 | 2.823 | 4.332 | |
| P值 | 0.015 | <0.001 | <0.001 | <0.001 | 0.007 | <0.001 |
| 组别 | 例数 | CD3+T细胞/% | CD4+T细胞/% | CD8+T细胞/% | CD4+/CD8+比值 | NK细胞/% | 总B细胞/% |
|---|---|---|---|---|---|---|---|
| 维生素D正常组 | 32 | 70.13±11.14 | 36.13±7.23 | 37.91±14.18 | 0.98±0.27 | 9.96±4.05 | 14.21±2.99 |
| 维生素D不足组 | 20 | 88.44±18.46 | 24.12±4.28 | 58.46±17.36 | 0.57±0.18 | 7.32±2.02 | 10.02±2.11 |
| t值 | 2.530 | 7.606 | 7.769 | 5.154 | 2.823 | 4.332 | |
| P值 | 0.015 | <0.001 | <0.001 | <0.001 | 0.007 | <0.001 |
| [1] |
张艳. 抗Sm抗体、抗U1-RNP抗体阳性检测结果与临床诊断不符1例报道[J]. 检验医学, 2022, 37(9):892-893.
DOI |
| [2] | 王敏, 叶凤, 王善志. 系统性红斑狼疮患者合并肾脏损害与血清25羟基维生素D3水平的关系[J]. 临床和实验医学杂志, 2022, 21(14):1509-1512. |
| [3] |
QUINLAN C, MARKS S D, TULLUS K. Why are kids with lupus at an increased risk of cardiovascular disease?[J] Pediatr Nephrol, 2016, 31(6):861-883.
DOI PMID |
| [4] | ONI L, WRIGHT R D, MARKS S, et al. Kidney outcomes for children with lupus nephritis[J]. Pediatr Nephrol, 2021, 36(6):1377-1385. |
| [5] | FATEMI A, MATINFAR M, SMILEY A. Childhood versus adult-onset systemic lupus erythematosus:long-term outcome and predictors of mortality[J]. Clin Rheumatol, 2017, 36(2):343-350. |
| [6] | LIVINGSTON B, BONNER A, POPE J. Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus:a meta-analysis[J]. Semin Arthritis Rheum, 2012, 42(3):271-280. |
| [7] | SOUSA S, GONÇALVES M J, INÊS L S, et al. Clinical features and long-term outcomes of systemic lupus erythematosus:comparative data of childhood,adult and late-onset disease in a national register[J]. Rheumatol Int, 2016, 36(7):955-960. |
| [8] | FULGERI C, CARPIO J D, ARDILES L. Kidney injury in systemic lupus erythematosus:lack of correlation between clinical and histological data[J]. Nefrologia(Engl Ed), 2018, 38(4):386-393. |
| [9] | 董洋, 赵心迪, 王雁良, 等. 外周血淋巴细胞亚群在系统性红斑狼疮患者中表达及与狼疮性肾炎的关系[J]. 中华实用诊断与治疗杂志, 2023, 37(6):591-595. |
| [10] | 陈珊, 蒋红宇, 吴轶颖, 等. 血清25-羟维生素D3和T淋巴细胞亚群与儿童哮喘发病风险和控制水平的关系[J]. 中国卫生检验杂志, 2023, 33(5):572-575. |
| [11] | 贾丽媛, 王丽, 温丽, 等. 急性淋巴细胞白血病患儿血清25羟维生素D3、乳酸脱氢酶、白细胞介素-6水平与危险度分层和预后不良的关系研究[J]. 现代生物医学进展, 2022, 22(11):2166-2170. |
| [12] | 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会. 中国儿童系统性红斑狼疮诊断与治疗指南[J]. 中华儿科杂志, 2021, 59(12):1009-1024. |
| [13] | 夏维波, 李梅. 维生素D缺乏的评价、预防及治疗——内分泌学会临床实践指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2011, 4(2):144-146. |
| [14] | AGGARWAL A, SRIVASTAVA P. Childhood onset systemic lupus erythematosus:how is it different from adult SLE?[J]. Int J Rheum Dis, 2015, 18(2):182-191. |
| [15] | CANN M P, SAGE A M, MCKINNON E, et al. Childhood systemic lupus erythematosus:presentation,management and long-term outcomes in an Australian cohort[J]. Lupus, 2022, 31(2):246-255. |
| [16] | 石永兵, 沈华英, 施晓松, 等. 系统性红斑狼疮患者T淋巴细胞亚群及NK细胞变化及其临床意义[J]. 苏州大学学报(医学版), 2005, 25(6):1033-1034. |
| [17] |
沈薇薇, 李宗锋, 卜秋宁, 等. MPV、PDW、铁蛋白在评估狼疮性肾炎患者肾损伤程度中的价值[J]. 检验医学, 2020, 35(1):33-36.
DOI |
| [18] |
李冰玲, 程雅婷, 赵蓓蓓, 等. LC-MS/MS检测血清25-羟基维生素D替代校准品基质的选择与评价[J]. 检验医学, 2021, 36(2):213-218.
DOI |
| [19] | 贾永娟, 刘杏立, 刘春冉, 等. 化学发光免疫法与液相色谱-串联质谱法检测人血清维生素B12的一致性评价[J]. 中国卫生检验杂志, 2023, 33(17):2069-2071. |
| [20] | MOK C C, BIRMINGHAM D J, LEUNG H W, et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus:relationship with disease activity,vascular risk factors and atherosclerosis[J]. Rheumatology(Oxford), 2012, 51(4):644-652. |
| [21] | LIPIŃSKA-OPAŁKA A, TOMASZEWSKA A, KUBIAK J Z, et al. Vitamin D and immunological patterns of allergic diseases in children[J]. Nutrients, 2021, 13(1):177. |
| [22] | 关锐, 冯莉, 李慧, 等. 血清IL-2Rα和25(OH)D及miR-200水平与系统性红斑狼疮患者疾病活动度及预后的关系[J]. 热带医学杂志, 2023, 23(3):346-351. |
| [23] | MOSTAFA G A, AL-AYADHI L Y. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism:relation to autoimmunity[J]. J Neuroinflammation, 2012, 9:201. |
| [24] | TONIATO E, SPINAS E, SAGGINI A, et al. Immunomodulatory effects of vitamin D on skin inflammation[J]. J Biol Regul Homeost Agents, 2015, 29(3):563-567. |
| [25] | MATTOZZI C, PAOLINO G, RICHETTA A G, et al. Psoriasis,vitamin D and the importance of the cutaneous barrier's integrity:an update[J]. J Dermatol, 2016, 43(5):507-514. |
| [26] | 徐玉娟, 李芬, 李胜涛, 等. 维生素D制剂干预对单纯性肥胖学龄前儿童免疫功能及血清脂肪因子水平的影响[J]. 中国临床研究, 2021, 34(1):61-64. |
| [27] |
HEWISON M. Antibacterial effects of vitamin D[J]. Nat Rev Endocrinol, 2011, 7(6):337-345.
DOI PMID |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||